Month: May 2024

BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next...

Strong First Quarter Growth Driven by Performance Across Unified Commerce Platform Contacts Priority Investor Inquiries: Chris Kettmann chris.kettmann@dentonsglobaladvisors.com (773) 497-7575...

Delivered another record quarter, exceeding guidance on all metrics: Record Network Volume of $2.42 billion Record Total Revenue and Other...

REHOVOT, Israel, May 9, 2024 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced financial results for the first quarter, the three-month...

CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on...

Contacts Investors Sean K. F. Hannan Head of Investor Relations 978-614-4374 IR@netscout.com Media Chris Lucas AVP, Marketing & Corporate Communications...

Contacts Investors and Media: Felix Veksler Senior Director, Investor Relations ir@monro.com Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive...

Contacts Tim Surgenor ir@merrimack.com Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that the Board of Directors...

THE WOODLANDS, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the...

TROY, Mich., May 09, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced...

TROY, Mich., May 09, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced...

- Announced plans to pursue additional autoimmune disease regulatory filings for its iPSC derived NK cell therapy, CNTY-101, beyond systemic...

Contacts Pat Jackson, Chief Financial Officer pjackson@ingles-markets.com (828) 669-2941 (Ext. 223) Ingles Markets, Incorporated (NASDAQ: IMKTA) today reported sales for...

Contacts Media Wendy Goldberg Chief Communications Officer (212) 377-1105 wendygoldberg@iheartmedia.com Investors Mike McGuinness EVP, Deputy CFO, and Head of Investor...

CHICAGO, May 09, 2024 (GLOBE NEWSWIRE) -- Whole Earth Brands, Inc. (the “Company” or “we” or “our”) (Nasdaq: FREE), a...

EDISON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), a leading...

HOUSTON, TX / ACCESSWIRE / May 9, 2024 / ENGlobal Corporation (NASDAQ:ENG), a provider of innovative engineering project solutions focused...

Completed oversubscribed $50 million private placementFirst participant dosed in clinical trial at University of Chicago Medicine assessing the use of...

CANTON, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of...

Industry-leading balance sheet with $855 million in cash and cash equivalentsNet revenue in Q1 2024 increased by 30% year-over-year to...

BERKELEY HEIGHTS, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

CAMBRIDGE, MA, May 09, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey...

PDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparationsStrong balance sheet supports commercialization and pipeline expansionRead...

Record First Quarter Net Revenue of $147.9 million, up 24.1% versus Prior Year PeriodRaises Fiscal Year 2024 OutlookAnnounces Plans for...

BEIJING, May 09, 2024 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft Cloud” or the...

Contacts Press Inquiries pr@energyrecovery.com Investor Inquiries ir@energyrecovery.com Energy Recovery, Inc. (Nasdaq: ERII) today announced $15 million in contracts to supply...

- Royalty revenue of $10.7 million, up 33% year-over-year, generated from 371 million shipped units, up 25% year-over-year - 11...

     Advancing TRANQUILITY and SERENITY program plans for two pivotal Phase 3 trials to expand BXCL501 market potential in acute...

Contacts Justin Ward Sr. Director, Investor Relations & Corporate Development Bruker Corporation T: +1 (978) 313-5800 E: Investor.Relations@bruker.com Bruker Corporation...

- First patient start (cell collection) for LYFGENIA completed – - 15 patient starts to date in 2024 (11 ZYNTEGLO,...

AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform...

RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on...

SUNNYVALE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a developer of cellular and cell-derived therapeutics for the...

Continued Enrollment in Global Phase 3 CoMpass Trial in Small Choroidal Melanoma and Indeterminate Lesions Ongoing Phase 1 Trial in...

SAN MATEO, Calif. and SINGAPORE, May 09, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company...

LONDON, May 09, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, today urges...

LONDON, May 09, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, today urges...